139958-51-3
Chemical Structure
13-O-Desmethyl tacrolimus
Synonym(s): 13-DMT; 13-O-Demethyl FK 506
- CAS No.: 139958-51-3
- Formula:C43H67NO12
- Molecular Weight:789.99
InChIKey: OGJRKILIPRVJFS-MNAQQUBESA-N
SMILES: CO[C@@H]1[C@@]2([H])O[C@@](C(C(N3[C@](CCCC3)([H])C(O[C@@H]([C@@H]([C@H](CC([C@@H](/C=C(C[C@@H](C1)C)\C)CC=C)=O)O)C)/C(C)=C/[C@H]4C[C@H]([C@@H](CC4)O)OC)=O)=O)=O)([C@@H](C[C@@H]2O)C)O
Biological Activity: 13-O-Desmethyl tacrolimus (13-DMT; 13-O-Demethyl FK 506) is the major metabolite of Tacrolimus (HY-13756) formed via cytochrome P450 3A-mediated biotransformation. The ratio of 13-O-Desmethyl tacrolimus to Tacrolimus serves as a biomarker for myelotoxicity and hepatotoxicity[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
13-O-Desmethyl tacrolimus | 13-O-Desmethyl tacrolimus (13-DMT; 13-O-Demethyl FK 506) is the major metabolite of Tacrolimus (HY-13756) formed via cytochrome P450 3A-mediated biotransformation. The ratio of 13-O-Desmethyl tacrolimus to Tacrolimus serves as a biomarker for myelotoxicity and hepatotoxicity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Zegarska J, et al. Evaluation of the Relationship Between Concentrations of Tacrolimus Metabolites, 13-O-Demethyl Tacrolimus and 15-O-Demethyl Tacrolimus, and Clinical and Biochemical Parameters in Kidney Transplant Recipients. Transplant Proc. 2018 Sep;50(7):2235-2239. [Content Brief]
- [2]. Kirresh T, et al. Development and validation of a liquid chromatography-mass spectrometric assay for simultaneous determination of tacrolimus and 13-O-desmethyl tacrolimus in rat kidney tissue. Journal of pharmaceutical and biomedical analysis. 2017 Mar 20;136:32-37.
Keywords
